KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 0.36.

  • Regeneron Pharmaceuticals' Asset Utilization Ratio fell 592.2% to 0.36 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.36, marking a year-over-year decrease of 592.2%. This contributed to the annual value of 0.37 for FY2025, which is 865.15% down from last year.
  • Regeneron Pharmaceuticals' Asset Utilization Ratio amounted to 0.36 in Q4 2025, which was down 592.2% from 0.36 recorded in Q3 2025.
  • Regeneron Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.65 for Q4 2021, and its period low was 0.21 during Q4 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.38 (2024), whereas its average is 0.41.
  • In the last 5 years, Regeneron Pharmaceuticals' Asset Utilization Ratio crashed by 6808.04% in 2022 and then skyrocketed by 9245.2% in 2023.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Asset Utilization Ratio stood at 0.65 in 2021, then plummeted by 68.08% to 0.21 in 2022, then skyrocketed by 92.45% to 0.4 in 2023, then dropped by 6.07% to 0.38 in 2024, then dropped by 5.92% to 0.36 in 2025.
  • Its last three reported values are 0.36 in Q4 2025, 0.36 for Q3 2025, and 0.38 during Q2 2025.